News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ANG ROBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $2.67, valued at
$6.3k
|
|
| 05/10/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $4.14, valued at
$9.8k
|
|
| 03/02/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 12,657 shares
@ $5.51, valued at
$69.7k
|
|
| 02/08/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 128,750 shares
@ $0
Granted 257,500 options to buy
@ $5.55, valued at
$1.4M
|
|
| 09/15/2022 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 172,500 shares
@ $0
Granted 172,500 options to buy
@ $4.97, valued at
$857.3k
|
|
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/01/2019 |
4
| ANG ROBERT (Chief Business Officer) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $6.13, valued at
$245.2k
|
|
| 06/26/2018 |
3
| ANG ROBERT (Chief Business Officer) has filed a Form 3 on Neon Therapeutics, Inc. |
|
|